The rise of IL-2 therapy - a picture beyond T_reg cells

Zhanguo Li¹, Jing He¹, Di Yu²

Affiliations

¹ Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, 100044, Beijing, China.
² Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia.

PMID: 28490785
DOI: 10.1038/nrrheum.2017.70

Comment

The rise of IL-2 therapy - a picture beyond T_reg cells

Zhanguo Li et al. Nat Rev Rheumatol. 2017 Jun.

. 2017 Jun;13(6):386.

doi: 10.1038/nrrheum.2017.70. Epub 2017 May 11.

Authors

Zhanguo Li¹, Jing He¹, Di Yu²

Affiliations

¹ Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, 100044, Beijing, China.
² Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia.

PMID: 28490785
DOI: 10.1038/nrrheum.2017.70

No abstract available

PubMed Disclaimer

Comment in

Low-dose IL-2 therapy - a complex scenario that remains to be further explored.
Humrich JY, Riemekasten G. Humrich JY, et al. Nat Rev Rheumatol. 2017 Jun;13(6):386. doi: 10.1038/nrrheum.2017.71. Epub 2017 May 11. Nat Rev Rheumatol. 2017. PMID: 28490788 No abstract available.

Comment on

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, Jin Y, Gan Y, Hu X, Jia R, Xu C, Hou Z, Leong YA, Zhu L, Feng J, An Y, Jia Y, Li C, Liu X, Ye H, Ren L, Li R, Yao H, Li Y, Chen S, Zhang X, Su Y, Guo J, Shen N, Morand EF, Yu D, Li Z. He J, et al. Nat Med. 2016 Sep;22(9):991-3. doi: 10.1038/nm.4148. Epub 2016 Aug 8. Nat Med. 2016. PMID: 27500725

References

1. Immunity. 2012 May 25;36(5):847-56 - PubMed
1. Nat Rev Rheumatol. 2016 Dec;12 (12 ):695-696 - PubMed
1. J Exp Med. 2006 Jul 10;203(7):1701-11 - PubMed
1. Ann Rheum Dis. 2016 Jul;75(7):1407-15 - PubMed
1. Immunity. 2013 Oct 17;39(4):770-81 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The rise of IL-2 therapy - a picture beyond T_reg cells

Affiliations

The rise of IL-2 therapy - a picture beyond T_reg cells

Authors

Affiliations

Comment in

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical